Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
extrapolated AUC fraction | part of the total estimated exposure derived from extrapolation | The extrapolated AUC fraction was reviewed because the late sampling period was short. | Assessment | Drug concentrations, exposure and assay interpretation |
first-pass extraction | presystemic removal before an absorbed dose reaches systemic circulation | The route change prompted review of possible first-pass extraction. | Assessment | Drug concentrations, exposure and assay interpretation |
hepatic extraction ratio | fraction of drug removed from blood during one passage through the liver | The pharmacology note distinguishes the hepatic extraction ratio from total clearance. | Assessment | Drug concentrations, exposure and assay interpretation |
icterus index | instrument estimate of bilirubin-related specimen discoloration | The icterus index exceeded the assay's stated interference threshold. | Objective | Drug levels - analyte, specimen and reporting |
individual parameter estimate | model-derived value for a specific person's pharmacokinetic parameter | The individual parameter estimate was updated after the second timed measurement. | Assessment | Drug concentrations, exposure and assay interpretation |
inoculum effect | observed antimicrobial activity changes with the starting number of organisms tested | Inoculum effect was discussed with microbiology in relation to the assay. | Assessment | Infection course, epidemiology and source attribution |
interindividual variability | differences in a parameter among different people | The report distinguishes interindividual variability from uncertainty in this patient's estimate. | Assessment | Drug concentrations, exposure and assay interpretation |
intraindividual variability | change in a parameter or result within the same person over time | The repeated levels suggest intraindividual variability across illness episodes. | Assessment | Drug concentrations, exposure and assay interpretation |
intrinsic clearance | capacity of an organ's eliminating machinery independent of flow and binding in the model | The report lists intrinsic clearance as a model parameter. | Assessment | Drug concentrations, exposure and assay interpretation |
islet autoantibodies | antibodies against specified pancreatic islet targets | Islet autoantibodies were reviewed individually with the assay results. | Objective | Glucose monitoring, endocrine testing and urine studies |
kappa-to-lambda ratio | ratio of measured kappa and lambda light chains | The kappa-to-lambda ratio was interpreted against the appropriate assay reference. | Objective | Glucose monitoring, endocrine testing and urine studies |
ketonemia | increased ketones in blood | The serum assay documents ketonemia. | Objective | Electrolytes, acid-base and metabolic testing |
laboratory method confirmation | checking the method used to generate a specific result | Request laboratory method confirmation before comparing the new result with the historical assay. | Plan | Sampling, laboratory verification and communication |
limited sampling strategy | specified subset of timed measurements used to estimate an exposure metric | The report names the validated limited sampling strategy used for the AUC estimate. | Assessment | Drug concentrations, exposure and assay interpretation |
matrix effect | influence of other components of the sample on analytical response | The laboratory considered a matrix effect when the results differed by method. | Assessment | Drug concentrations, exposure and assay interpretation |
matrix mismatch | specimen type differs from that assumed by the comparator | A matrix mismatch limits comparison of this plasma result with the whole-blood target. | Assessment | Drug concentrations, exposure and assay interpretation |
maximum clot firmness | peak clot strength on a rotational viscoelastic tracing | Maximum clot firmness was recorded for the specified assay channel. | Objective | Coagulation, antibodies and hemostasis studies |
measurable residual disease | low-level disease detected after treatment by a specified sensitive method | Measurable residual disease was reported with assay sensitivity and specimen source. | Assessment | Cancer, treatment response and transplant assessment |
method comparison | assessment of how results differ between analytical techniques | The method comparison used paired specimens tested on both platforms. | Assessment | Drug concentrations, exposure and assay interpretation |
microbiologic persistence | organism remains detectable on relevant repeat testing | Microbiologic persistence was interpreted in light of whether the assay reflects viable organisms. | Assessment | Infection course, epidemiology and source attribution |
model misspecification | model structure does not adequately describe the observed data | The mismatch between several timed samples raises concern for model misspecification. | Assessment | Drug concentrations, exposure and assay interpretation |
nonrenal clearance | drug elimination through routes other than the kidneys | The review considered a change in nonrenal clearance during the acute illness. | Assessment | Drug concentrations, exposure and assay interpretation |
observed-to-predicted ratio | measured value divided by the model prediction at that time | The observed-to-predicted ratio was recalculated after the collection time was corrected. | Assessment | Drug concentrations, exposure and assay interpretation |
partial AUC | area under the concentration-time curve over a defined subinterval | The partial AUC was reported for the first four hours with the interval specified. | Assessment | Drug concentrations, exposure and assay interpretation |
peak-to-trough fluctuation | extent of change between highest and lowest concentrations across a dosing interval | The report defines the calculation used for peak-to-trough fluctuation. | Assessment | Drug concentrations, exposure and assay interpretation |